Claudio Jeldres

Prix et distinctions

• 1st Prize Clinical Essay Award and Session's Best Poster European Association of Urology. (EAU), 24th Annual Congress, Stockholm. (Prix).
• Ambassadeur milieu hospitalier. Fondation du CHUS. (Prix).
• Clinical Research 1st prize Association des urologues du Québec. (AUQ), 9e Congrès annuel, Québec. (Prix).
• Doctoral Training for Medical Students award. Fonds de recherche du Québec - Santé (FRQS). (Prix).
• Fellow scholarship. Fondation de l'Association des urologues du Québec. (Prix).
• Fellow scholarship. Fondation de l'Association des urologues du Québec (AUQ), Canada. (Prix).
• Prix d'excellence pour la meilleure présentation. 37e Journée scientifique du Département de chirurgie du CHUM, Montréal. (Prix).
• Prix d'excellence pour la meilleure présentation vidéo. 39e Journée scientifique du Département de chirurgie du CHUM, Montréal. (Prix).
• Research Excellence Scholarship. Fonds des Professionnels, Faculté de médecine, Université de Montréal. (Prix).
• Session's Best Poster Award European Association of Urology. EAU 22nd Annual Congress, Berlin. (Distinction).

Financement

• Subvention. (Obtenu). Collaborateur. Urine biomarkers for bladder cancer diagnosis and surveillance: a multicentric study to assess the diagnostic accuracy of a comprehensive diagnostic tool.. Organisation Mondiale de la Santé (OMS). ERA PerMed JTC2022. 1 024 118 $. (2023-2026)
• Subvention. (Obtenu). Cocandidat. Challenge Grant program from the Canadian Cancer Society (CHA-22). Société Canadienne du Cancer. Challenge Grant program. 300 000 $. (2021-2023)
• Subvention. (Obtenu). Chercheur principal. Conduit urinaire artificiel. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). PAFI. 25 000 $. (2018-2020)
• Subvention. (Obtenu). Chercheur principal. Nouveaux biomarqueurs urinaires pour la détection de récidive tumorale: les événements d'épissage alternatif comme nouvel outil diagnostic chez les patients atteints du cancer de la vessie. Université de Sherbrooke. Programme de subventions Merck Sharp & Dohme. 67 000 $. (2017-2018)

Publications

Articles de revue

• Marcq G , Kool R , Dragomir A , Kulkarni GS , Breau RH , Kim M , Busca I , Abdi H , Dawidek M , Uy M , Fervaha G , Alimohamed N , Izawa J , Jeldres C , Rendon R , Shayegan B , Siemens R , Black PC , Cury FL , Kassouf W. (2025). Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 43 (3), 308-317. (Article publié).
• Avolio PP , Kool R , Shayegan B , Marcq G , Black PC , Breau RH , Kim M , Busca I , Abdi H , Dawidek M , Uy M , Fervaha G , Cury FL , Sanchez-Salas R , Alimohamed N , Izawa J , Jeldres C , Rendon R , Siemens R , Kulkarni GS , Kassouf W. (2025). Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer. International journal of radiation oncology, biology, physics 121 (2), 317-324. (Article publié).
• Thériault R , Ismail S , Morin C , Bouchard F , Tétreault-Laflamme A , Richard PO , Jeldres C , Tu LM. (2025). Long-term urinary complications in patients with localized prostate cancer treated with radiotherapy and/or radical prostatectomy. World journal of urology 43 (1), 503. (Article publié).
• Kool R , Dragomir A , Kulkarni GS , Marcq G , Breau RH , Kim M , Busca I , Abdi H , Dawidek M , Uy M , Fervaha G , Cury FL , Alimohamed N , Izawa J , Jeldres C , Rendon R , Shayegan B , Siemens R , Black PC , Kassouf W. (2024). Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis. European urology oncology 7 (6), 1350-1357. (Article publié).
• Halstuch D , Kool R , Marcq G , Breau RH , Black PC , Shayegan B , Kim M , Busca I , Abdi H , Dawidek MT , Uy M , Fervaha G , Cury FL , Alimohamed NS , Jeldres C , Rendon R , Brimo F , Siemens DR , Kulkarni GS , Kassouf W , Izawa JI. (2024). The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer. The Journal of urology 212 (5), 710-719. (Article publié).
• McLoughlin, LC; Kassouf,,W; Breau, RH; Fairey, A; Agnihotram, V R; Salimi, A; Hyndman, E; Drachenberg, DE; Izawa, J; Shayegan, B; Lattouf, JB; Lodde, M; Rendon, R; Siemens, DR; Jeldres, C; Black, PC; Kulkarni, GS. (2023). Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index Threshold. The Journal of urology 209 (1), 111-120. (Article publié).
• Kool, R;,Marcq, G; Breau, RH; Black, PC; Shayegan, B; Kim, M; Busca, I; Abdi, H; Dawidek, MT; Uy, M; Fervaha, G; Cury, FL; Alimohamed, NS; Izawa, JI; Jeldres, C; Rendon, R; Siemens, DR; Kulkarni, GS; Kassouf, W. (2023). Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers. European urology oncology 23 00068-8. (Article publié).
• Charbonneau, M; Harper, K; Brochu-Gaudreau, K; Perreault, A; McDonald, PP; Ekindi-Ndongo, N; Jeldres, C; Dubois, CM. (2022). Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing. Frontiers in medicine 9 1003914. (Article publié).
• Harper, K; Yatsyna, A; Charbonneau, M; Brochu-Gaudreau, K; Perreault, A; Jeldres, C; McDonald,PP; Dubois, CM. (2021). The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis. Cancers 13 (5), 1093. (Article publié).
• Kassouf W , Aprikian A , Saad F , Fleshner N , Alimohamed N , Breau RH , Brimo F , Chin J , Chung P , Cornacchia T , Devins F , Eapen L , Eigl B , Fairey A , Guttman D , Izard JP , Jacobsen N , Jeldres C , Kulkarni G , Lalani AK , Lodde M , Lukka H , Moore R , Morash C , North S , Northam T , Ong M , Power N , Rendon R , Purves R , Shayegan B , Smith R , So A , Sridhar SS , Zlotta A , Siemens DR , Black PC. (2020). Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 14 (3), E115-E125. (Article publié).
• R S , N E , C J. (2020). Unique urethral metastasis from renal cell carcinoma: Late relapse after radical nephrectomy in a young patient. Urology case reports 33 101352. (Article publié).
• Karakiewicz, PI; Zaffuto, E; Kapoor, A; Basappa, NS; Bjarnason, GA; Blais, N; Breau, RH; Canil, C; Drachenberg, D; Hotte, SJ; Jeldres, C; Jewett, MAS; Kassouf, W; Kollmannsberger, C; Lavallée, LT; Maloni ,R; Patenaude, F; Pouliot, F; Reaume, MN; Sabbagh, R; Shayegan, B; So, A; Soulières, D; Tanguay, S; Wood, L; Bandini, M. (2018). KCRNC consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Canadian Urological Association journal 12 (6), 173-180. (Article publié).
• Simard H , Sabbagh R , Ouellet S , Richard P , Jeldres C. (2018). The impact of targeted therapy on healthcare resource use in patients with metastatic renal cell carcinoma: The University of Sherbrooke experience. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 12 (9), E373-E377. (Article publié).
• Richard PO , Ahmad AE , Bashir S , Hamilton RJ , Nam RK , Leao R , Jeldres C , Kulkarni GS. (2017). Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis. Urologic oncology 35 (6), 342-348. (Article publié).
• Richard PO, Ahmad AE, Bashir S, Hamilton RJ, Nam RK, Leao R, Jeldres C, Kulkarni GS. (2017). Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis. Urol Oncol. 35 (6), 342-348. (Article publié).
• Djuimo M, Aubé M, Beland M, Jeldres C, Carmel M, Benko A. (2017). Lumbar Artery Pseudoaneurysm: A Complication of Percutaneous Nephrostomy. Urol Case Rep. 13 66-68. (Article publié).
• Djuimo M , Aubé M , Beland M , Jeldres C , Carmel M , Benko A. (2017). Lumbar Artery Pseudoaneurysm: A Complication of Percutaneous Nephrostomy. Urology case reports 13 66-68. (Article publié).
• Reaume, MN; Basappa, NS; Wood, L; Kapoor, A; Bjarnason, GA; Blais, N; Breau, RH; Canil, C; Cheung, P; Conter, HJ; Hotte, SJ; Jeldres, C; Jewett, MAS; Karakiewicz, PI; Kollmannsberger, C; Patenaude, F; So, A; Soulières, D; Venner, P; Violette, P; Zalewski, P; Chappell, H; North, SA; Kidney Cancer Research Network of Canada. (2017). Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017. Canadian Urological Association journal 11 (10), 310-320. (Article publié).
• Tandstad T, Kollmannsberger CK, Roth BJ, Jeldres C, Gillessen S, Fizazi K, Daneshmand S, Lowrance WT, Hanna NH, Albany C, Foster R, Cedermark GC, Feldman DR, Powles T, Lewis MA, Grimison PS, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl GJ, Nichols CR. (2017). Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm. J Clin Oncol. 35 (31), 3525-3528. (Article publié).
• Ouellet, S; Sabbagh, R; Jeldres, C. (2017). Transperitoneal laparoscopic nephrectomy: Assessing complication risk in cases of previous abdominal surgery. Canadian Urological Association journal 11 (3-4), 131-135. (Article publié).
• Ouellet S, Sabbagh R, Jeldres C. (2017). Transperitoneal laparoscopic nephrectomy: Assessing complication risk in cases of previous abdominal surgery. Can Urol Assoc J. 11 (3-4), 131-135. (Article publié).
• Trudeau V , Larcher A , Boehm K , Dell'Oglio P , Sun M , Tian Z , Briganti A , Shariat SF , Jeldres C , Karakiewicz PI. (2016). Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study. Urology 89 63-7. (Article publié).
• Pham, KN; Jeldres, C; Hefty, T; Corman, JM. (2016). Endoscopic Management of Bladder Diverticula. Rev Urol. 18 (2), 114-117. (Article publié).
• Qu X , Jeldres C , Glaskova L , Friedman C , Schroeder S , Nelson PS , Porter C , Fang M. (2016). Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence. The Journal of molecular diagnostics : JMD 18 (2), 215-24. (Article publié).
• Bishr, M; Boehm, K; Trudeau, V; Tian, Z; Dell'Oglio, P; Schiffmann, J; Jeldres, C; Sun, M; Shariat, SF; Graefen, M; Saad, F; Karakiewicz, PI. (2016). Medical management of benign prostatic hyperplasia: Results from a population-based study. Canadian Urological Association journal 10 (1-2), 55-9. (Article publié).
• Hugen, CM; Hu, B; Jeldres, C; Burton, C; Nichols, CR; Porter, CR, Daneshmand, S. (2016). Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011). Urol Oncol. 34 (11), 487.e7-487.e11. (Article publié).
• Ouellet S , Jeldres C , Simard H , Sabbagh R , Carmel M. (2015). Open cystolithotomy for very large calculi in a Studer ileal neobladder. The Canadian journal of urology 22 (6), 8112-4. (Article publié).
• Jeldres C , Cullen J , Hurwitz LM , Wolff EM , Levie KE , Odem-Davis K , Johnston RB , Pham KN , Rosner IL , Brand TC , L'Esperance JO , Sterbis JR , Etzioni R , Porter CR. (2015). Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer 121 (14), 2465-73. (Article publié).
• Pham KN , Johnston RB , Jeldres C , Lewinshtein DJ , Porter CR. (2015). The Impact of Multiple Prostate Needle Biopsies on Long-Term Erectile Dysfunction. Urology practice 2 (2), 85-89. (Article publié).
• Pham KN , Porter CR , Odem-Davis K , Wolff EM , Jeldres C , Wei JT , Morgan TM. (2015). Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?. The Journal of urology 194 (3), 674-9. (Article publié).
• Pham KN , Johnston RB , Jeldres C , Nichols CR , Porter CR. (2014). Modeling Management Strategies for Clinical Stage I Seminoma: Direct and Indirect Costs for the First 5 Years. Urology practice 1 (3), 151-155. (Article publié).
• Trinh QD , Bianchi M , Sun M , Sammon J , Schmitges J , Shariat SF , Sukumar S , Jeldres C , Zorn K , Perrotte P , Rogers CG , Peabody JO , Montorsi F , Menon M , Karakiewicz PI. (2013). Discharge patterns after radical prostatectomy in the United States of America. Urologic oncology 31 (7), 1022-32. (Article publié).
• Fajkovic H , Cha EK , Jeldres C , Robinson BD , Rink M , Xylinas E , Chromecki TF , Breinl E , Svatek RS , Donner G , Tagawa ST , Tilki D , Bastian PJ , Karakiewicz PI , Volkmer BG , Novara G , Joual A , Faison T , Sonpavde G , Daneshmand S , Lotan Y , Scherr DS , Shariat SF. (2013). Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. European urology 64 (5), 837-45. (Article publié).
• Sammon JD , Trinh QD , Sukumar S , Ravi P , Friedman A , Sun M , Schmitges J , Jeldres C , Jeong W , Mander N , Peabody JO , Karakiewicz PI , Harris M. (2013). Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location. Urologic oncology 31 (8), 1470-6. (Article publié).

Chapitres de livre

• (2013). 33 histoires vraies racontées par des médecins. Furger P et al. Éditions D&F, Québec, Canada, 2013, ISBN 97803905699-25-8 (Article publié).

Articles de journaux

• Richard PO, Ahmad AE, Bashir S, Hamilton RJ, Nam RK, Leao R, Jeldres C, Kulkarni GS. (2017). Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis. Urol Oncol. 2017 Jun;35(6):342-348.
• Djuimo M, Aubé M, Beland M, Jeldres C, Carmel M, Benko A. (2017). Lumbar Artery Pseudoaneurysm: A Complication of Percutaneous Nephrostomy. Urol Case Rep. 2017 Apr 26;13:66-68.
• Tandstad T, Kollmannsberger CK, Roth BJ, Jeldres C, Gillessen S, Fizazi K, Daneshmand S, Lowrance WT, Hanna NH, Albany C, Foster R, Cedermark GC, Feldman DR, Powles T, Lewis MA, Grimison PS, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl GJ, Nichols CR. (2017). Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm. J Clin Oncol. 2017 Nov 1;35(31):3525-3528.
• Ouellet S, Sabbagh R, Jeldres C. (2017). Transperitoneal laparoscopic nephrectomy: Assessing complication risk in cases of previous abdominal surgery. Can Urol Assoc J. 2017 Mar-Apr;11(3-4):131-135.
• Trudeau V, Larcher A, Boehm K, Dell’Oglio P, Sun M, Tian Z, Briganti A, Shariat SF, Jeldres C, Karakiewicz PI. (2016). Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1 a Renal Cell. Urology 2016 Mar;89-63-7.
• Pham KN, Jeldres C, Hefty T, Corman JM. (2016). Endoscopic Management of Bladder Diverticula. Rev Urol. 2016;18(2): 114-7.
• Qu X, Jeldres C, Glaskova L, Friedman C, Schroeder S, Nelson PS, Porter C, Fang M. (2016). Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence. J Mol Diagn. 2016 Mar;18(2):215-24.
• Bishr M, Boehm K, Trudeau V, Tian Z, Dell’Oglio P, Schiffmann J, Jeldres C, Sun M, Shariat SF, Graefen M, Saad F, Karakeiwicz PI. (2016). Medical management of benign prostatic hyperplasia: Results from a population-based study. Can Urol Assoc J. 2016 Jan-Feb;10(1-2):55-9.
• Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L’Esperance JO, Stervis JR, Etzioni R, Porter CR. (2016). Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance. Cancer 2016 Jul 15;121(14):2465-73.
• Hugen CM, Hu B, Jeldres C, Burton C, Nichols CR, Porter CR, Daneshmand S. (2016). Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011). Urol Oncol. 2016 Nov;34(11):487.
• Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, DEnzinger S, Fradet Y, Isbarn H, Bastian PJ, Velkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF. (2015). Corrigendum to “Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort”. Eur Urol. 2015 Jul;68(1):171.
• Ouellet S, Jeldres C, Simard H, Sabbagh R, Carmel M. (2015). Open cystolithotomy for very large calculi in a Studer ileal neobladder. Can J Urol. 2015 Dec;22(6):8112-4.
• Pharm KN, Porter CR, Odem-Davis K, Wolff EM, Jeldres C, Wei JT, Morgan TM. (2015). Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance – How Many Cores are Enough?. J Urol 2015 Sep;194(3):674-9.
• Trinh QD, Sukumar S, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon JD, Jeldres C, Zorn KC, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. (2013). Effect of nodal metastases on cancerspecific mortality after cytoreductive nephrectomy. Annals of Surgical Oncology, 20(6):2096-102, 2013.
• Abdollah F, Gandaglia G, Thuret R, Schmitges J, Tian Z, Jeldres C, Passoni NM, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI, Sun M. (2013). Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. Cancer Epidemiology, 37(3):219-25, 2013.
• Schmitges J, Sun M, Abdollah F, Trinh QD, Jeldres C, Budaüs L, Bianchi M, Hansen J, Schlomm T, Perrotte P, Graefen M, Karakiewicz PI. (2012). Blood Transfusions in Radical Prostatectomy: A Contemporary Populationbased Analysis. Urology, 79(2):332-8, 2012.
• Abdollah F, Schmitges J, Sun M, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI. (2012). Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis. International Journal of Urology, May 2012.
• Abdollah F, Sun M, Schmitges J, Thuret R, Tian Z, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI. (2012). Competing-risks Mortality After Radiotherapy vs. Observation for Localized Prostate Cancer: A Population-based Study. Journal of Radiation Oncology Biology Physics, 84(1):95-103, 2012.
• Abdollah F, Sun M, Schmitges J, Thuret R, Djahangirian O, Jeldres C, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI. (2012). Development and Validation of a Reference Table for Prediction of Postoperative Mortality Rate in Patients Treated with Radical Cystectomy: A Population-based Study. Annals of Surgical Oncology, 19(1):309-17, 2012.
• Bianchi M, Trinh QD, Sun M, Sammon J, Schmitges J, Shariat SF, Sukumar S, Ghani KR, Jeldres C, Perrotte P, Rogers CG, Briganti A, Peabody JO, Montorsi F, Menon M, Karakiewicz PI. (2012). Discharge Patterns After Radical Cystectomy: Contemporary Trends in the United States. Journal of Urology, 187(4):1206-9, 2012.
• Trinh QD, Schmitges J, Sun M, Sammon J, Shariat SF, Sukumar S, Zorn K, Bianchi M, Jeldres C, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. (2012). Does partial nephrectomy at an academic institution result in better outcomes ?. World Journal of Urology, 30(4):505-10, 2012.
• Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. (2012). Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. European Urology, July 2012.
• Schmitges J, Trinh QD, Sun M, Hansen J, Bianchi M, Jeldres C, Perrotte P, Dahlem R, Shariat SF, Chun FK, Montorsi F, Menon M, Fisch M, Graefen M, Karakiewicz PI. (2012). Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis. BJU International, February 2012.
• Sun M, Bianchi M, Trinh QD, Abdollah F, Schmitges J, Jeldres C, Shariat SF, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. (2012). Hospital Volume is a Determinant of Postoperative Complications, Blood Transfusion and Length of Stay After Radical or Partial Nephrectomy. Journal of Urology, 187(2):405-10, 2012.
• Bianchi M, Trinh QD, Sun M, Meskawi M, Schmitges J, Shariat SF, Briganti A, TIan Z, Jeldres C, Sukumar S, Peabody JO, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI. (2012). Impact of academic affiliation on radical cystectomy outcomes in North America : A population-based study. Canadian Urological Association Journal, 6(4):245-50, 2012.
• Liberman D, Trinh QD, Jeldres C, Zorn KC. (2012). Is robotic surgery cost-effective: yes. Current Opinion in Urology, (1):61-5, 2012.
• Trinh QD, Sun M, Sammon J, Tian Z, Bianchi M, Shariat SF, Jeong W, Ghani KR, Jeldres C, Perrotte P, Agarwal PK, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. (2012). Leapfrog volume thresholds and perioperative complications after radical prostatectomy. Cancer, March 2012.
• Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI. (2012). Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. International. Journal of Urology, 19(7):645-51, 2012.
• Trinh QD, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon J, Jeldres C, Zorn K, Sukumar S, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI. (2012). Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort. BJU International, July, 2012.
• Fajkovic H, Cha EK, Jeldres C, Donner G, Chromecki TF, Margulis V, Novara G, Lotan Y, Raman JD, Kassouf W, Seitz C, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Breinl E, Pycha A, Ficarra V, Montorsi F, Karakiewicz PI, Scherr DS, Shariat SF. (2012). Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients With Upper Tract Urothelial Carcinoma. Journal of Urology, 187(3):845-51, 2012.
• Sun M, Abdollah F, Shariat SF, Schmitges J, Trinh QD, Tian Z, Jeldres C, Abdo A, Bianchi M, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI. (2012). Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: A national series. European Journal of Surgical Oncology, 38(1):80-7, 2012.
• Zorn KC, Trinh QD, Jeldres C, Schmitges J, Widmer H, Lattouf JB, Sammon J, Liberman D, Sun M, Bianchi M, Karakiewicz PI, Denis R, Gautam G, El-Hakim A. (2012). Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit. BJU International, 109(10):1526-32, 2012.
• Sammon JD, Trinh QD, Sukumar S, Ravi P, Friedman A, Sun M, Schmitges J, Jeldres C, Jeong W, Mander N, Peabody JO, Karakiewicz PI, Harris M. (2012). Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: A detailed assessment of margin extent and location. Urologic Oncology, April 2012.
• Abdollah F, Sun M, Schmitges J, Thuret R, Bianchi M, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI. (2012). Survival Benefit of Radical Prostatectomy in Patients with Localized Prostate Cancer: Estimations of the Number Needed to Treat According to Tumor and Patient Characteristics. Journal of Urology, 188(1):73-83, 2012.
• Sammon J, Trinh QD, Sun M, Bianchi M, Schmitges J, Shariat SF, Ghani KR, Sukumar S, Jeldres C, Briganti A, Perrotte P, Rogers CG, Peabody JO, Montorsi F, Menon M, Karakiewicz PI. (2012). The effect of gender on nephrectomy perioperative outcomes: a national survey. Canadian Journal of Urology, 19(4):6337-44, 2012.
• Liberman D, Trinh QD, Jeldres C, Valiquette L, Zorn KC. (2012). Training and outcome monitoring in robotic urologic surgery. Nature Reviews Urology, 9(1):17-22, 2012.
• Sun M, Abdollah F, Bianchi M, Trinh QD, Jeldres C, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI. (2012). Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift. Annals of Surgical Oncology, 19(7):2380-7, 2012.

Propriétés intellectuelles

Brevets

• François-Michel Boisvert, Martin Bisaillon, Sabrina Bouchard, Claudio Jeldres. Diagnostic test for the detection of bladder cancer in urine. 63/661,715. États-Unis d'Amérique. (En instance).

Autres contributions

Cours enseignés

• Source d'énergie au bloc opératoire: Anatomie du résectosocope. BGM722.

Gestion d'évènements

• organisateur et conférencier. Séminaire annuel d’introduction à la recherche pour les résidents du département de chirurgie (SIRR). (Séminaire).